A judge says that government and university labs have to share the patent rights to the successful cancer drug Velcade.
The Scientist
Most Recent
More than 100 environmental policy organizations call for greater oversight and regulation of synthetic biology.
The UK’s universities minister announces a plan for a new science and tech university funded entirely by non-government dollars.
A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.
Congress orders the Environmental Protection Agency to review the toxicity ratings of some chemicals and improve its process for making such assessments.
The National Institutes of Health promises about $400 million to help get personalized genetics into the clinic.
After a roller-coaster of an October, The Scientist resumes publication under new ownership.
Federal agencies offer interesting opportunities for researchers looking to do more than bench work.
The high court in Europe decided that researchers are barred from filing EU patents on work involving human embryonic stem cells.
The US government releases an updated list of potential carcinogens that includes seven new chemicals and biological agents
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
